Page last updated: 2024-11-03

procarbazine and Hypergonadotropic Hypogonadism

procarbazine has been researched along with Hypergonadotropic Hypogonadism in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research Excerpts

ExcerptRelevanceReference
"A patient with hypogonadotropic hypogonadism owing to endogenous gonadotropin releasing hormone deficiency, who developed Hodgkin's disease is described."1.28Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases? ( Nikolaou, N; Orfanos, S; Pavlidis, N; Tolis, C; Tolis, G, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pavlidis, N1
Nikolaou, N1
Tolis, C1
Orfanos, S1
Tolis, G1

Other Studies

1 other study available for procarbazine and Hypergonadotropic Hypogonadism

ArticleYear
Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases?
    Medical and pediatric oncology, 1989, Volume: 17, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Hodgkin Dis

1989